To overcome current cell model limitations, bit.bio have developed a new, innovative technology to reprogram human stem

As detailed in a separate post, bit.bio have developed a novel cellular reprogramming technology, opti-ox™

Synthetic mRNA is indeed the highway for today's therapeutics, whether you're working on developing new drugs against cancer targets, or whether you aim to develop new vaccines, Covid-19 being one of them.

Due to their involvement as checkpoints in immune cell responses, Sialic-acid-binding ImmunoGlobulin-like Lectins (Siglecs) have gained more and

Developed by Epicypher and available in Europe through tebu-bio, CUTANA CUT&RUN and its sister technology CUT&TAG are quickly becoming the preferred approaches for Chromatin Mapping

Propelled into the spotlight by the COVID-19 pandemic, mRNA has become a biological entity of great interest in drug discovery - yet mRNA vaccines are just the promising beginning, leading to more and

Since its emergence in 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has rapidly spread to become the major health issue of the past two years. But it's also a research field of interest

Many researchers are facing the challenges of mRNA delivery, through the body into the cytoplasm of cells. In this post, we invite you to discover some useful and efficient solutions to

You may have heard about the patented CryostaX^® format of hepatocyte pellets, but do you know why SEKISUI XenoTech and countless other researchers have made

Cell viability after cryopreservation is a sensitive subject as it may be dependent on the ability of mammalian cells to face the stress generated by the freeze / thaw cycles. Improving

Small molecules – overcome the barriers to clinical development

The potential of nanomedicine to provide therapeutic benefits over conventional drug formulations has been proven with a number of

How to make efficient Lipid Nanoparticles for RNA delivery

Even if RNA-based therapeutics have been under development for over 30 years, it was the COVID-19 pandemic that brought them into the